BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27696331)

  • 1. TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence.
    Cassar L; Nicholls C; Pinto AR; Chen R; Wang L; Li H; Liu JP
    Protein Cell; 2017 Jan; 8(1):39-54. PubMed ID: 27696331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3.
    Cassar L; Nicholls C; Pinto AR; Li H; Liu JP
    FASEB J; 2009 Jun; 23(6):1880-92. PubMed ID: 19193721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth.
    Cassar L; Li H; Pinto AR; Nicholls C; Bayne S; Liu JP
    Cancer Res; 2008 Nov; 68(22):9157-66. PubMed ID: 19010887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene.
    Li H; Liu JP
    Ann N Y Acad Sci; 2007 Oct; 1114():56-68. PubMed ID: 17934056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
    Jones KR; Elmore LW; Jackson-Cook C; Demasters G; Povirk LF; Holt SE; Gewirtz DA
    Int J Radiat Biol; 2005 Jun; 81(6):445-58. PubMed ID: 16308915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer.
    Yang H; Zhang H; Zhong Y; Wang Q; Yang L; Kang H; Gao X; Yu H; Xie C; Zhou F; Zhou Y
    Sci Rep; 2017 Feb; 7():41670. PubMed ID: 28195144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase.
    Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
    Chen R; Zhu J; Dong Y; He C; Hu X
    Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres.
    Goodwin EC; DiMaio D
    Cell Growth Differ; 2001 Nov; 12(11):525-34. PubMed ID: 11714633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
    Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
    J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.
    Patel PL; Suram A; Mirani N; Bischof O; Herbig U
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5024-33. PubMed ID: 27503890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human telomerase reverse transcriptase mediates the senescence of mesenchymal stem cells through the PI3K/AKT signaling pathway.
    Zhao Q; Wang XY; Yu XX; Zhai YX; He X; Wu S; Shi YA
    Int J Mol Med; 2015 Sep; 36(3):857-64. PubMed ID: 26178664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ActRIIA and BMPRII Type II BMP receptor subunits selectively required for Smad4-independent BMP7-evoked chemotaxis.
    Perron JC; Dodd J
    PLoS One; 2009 Dec; 4(12):e8198. PubMed ID: 20011660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activin inhibits telomerase activity in cancer.
    Katik I; Mackenzie-Kludas C; Nicholls C; Jiang FX; Zhou S; Li H; Liu JP
    Biochem Biophys Res Commun; 2009 Nov; 389(4):668-72. PubMed ID: 19769941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
    Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
    Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
    Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
    Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO E3 ligase CBX4 regulates hTERT-mediated transcription of CDH1 and promotes breast cancer cell migration and invasion.
    Sanyal S; Mondal P; Sen S; Sengupta Bandyopadhyay S; Das C
    Biochem J; 2020 Oct; 477(19):3803-3818. PubMed ID: 32926159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
    Babizhayev MA; Yegorov YE
    J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
    Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
    Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta and cancer: is Smad3 a repressor of hTERT gene?
    Li H; Xu D; Toh BH; Liu JP
    Cell Res; 2006 Feb; 16(2):169-73. PubMed ID: 16474430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.